Skip to main content
Universal Drugstore logo

Stiolto Respimat for COPD: How This Dual Bronchodilator Works and What to Expect

Managing chronic obstructive pulmonary disease (COPD) requires the right medication to help you breathe easier and maintain your quality of life. Stiolto Respimat (tiotropium bromide/olodaterol) is a prescription inhaler that combines two powerful bronchodilators in one convenient device. This dual-action medication is specifically designed for long-term maintenance treatment of COPD, including both chronic bronchitis and emphysema.

Shop Medications

,

Understanding how Stiolto Respimat works, when it’s prescribed, and what to expect can help you make informed decisions about your COPD treatment plan with your healthcare provider.

In This Article

What Is Stiolto Respimat?

Stiolto Respimat is a combination inhaler that contains two active ingredients: tiotropium bromide (2.5 mcg) and olodaterol (2.5 mcg) per actuation. These medications belong to different classes of bronchodilators, which are drugs that help open the airways in your lungs.

The FDA approved Stiolto Respimat for once-daily maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. It’s important to understand that this medication is not intended for treating sudden breathing problems or asthma attacks.

How Stiolto Respimat Works

The effectiveness of Stiolto Respimat comes from its dual mechanism of action. Each component targets different receptors in your lungs to provide comprehensive bronchodilation.

Tiotropium Bromide (LAMA)

Tiotropium belongs to a class of medications called long-acting muscarinic antagonists (LAMA). It works by blocking muscarinic receptors in the smooth muscle surrounding your airways. When these receptors are blocked, the muscles relax and the airways open wider, making it easier to breathe.

Olodaterol (LABA)

Olodaterol is classified as a long-acting beta2-adrenergic agonist (LABA). This medication activates beta2 receptors in the airway muscles, causing them to relax and stay open for extended periods. The combination of LAMA and LABA provides more comprehensive airway opening than either medication alone.

Together, these two bronchodilators work together to improve lung function and reduce COPD symptoms throughout the day with just one daily dose.

Proper Dosing and Administration

The standard dose of Stiolto Respimat is two inhalations once daily at the same time each day. Each inhalation delivers 2.5 mcg of tiotropium bromide and 2.5 mcg of olodaterol.

Important Administration Tips

To get the most benefit from your medication, follow these guidelines:

  • Timing: Take your medication at the same time each day to maintain consistent levels in your system.
  • Preparation: Prime your inhaler before first use and if you haven’t used it for more than three days.
  • Technique: Breathe out fully, place your lips around the mouthpiece, and inhale slowly and deeply while pressing the dose release button.
  • Follow-up: Hold your breath for about 10 seconds after inhaling, then breathe out slowly.

Your healthcare provider will demonstrate proper inhaler technique and may ask you to show them how you use it during follow-up visits.

Who Can Use Stiolto Respimat

Stiolto Respimat is specifically indicated for adults with COPD who need maintenance bronchodilator therapy. Your doctor might prescribe this medication if you have:

  • Moderate to severe COPD: Confirmed by spirometry testing showing airflow limitation.
  • Chronic bronchitis: Long-term inflammation of the airways with persistent cough and mucus production.
  • Emphysema: Damage to the air sacs in your lungs that makes breathing difficult.
  • Inadequate symptom control: Current symptoms despite using other COPD medications.

Clinical studies have shown that the combination of tiotropium and olodaterol provides superior lung function improvement compared to either medication used alone.

Common Side Effects

Like all medications, Stiolto Respimat can cause side effects, though not everyone experiences them. The most commonly reported side effects in clinical trials include:

  • Common cold symptoms: This includes a runny or stuffy nose, headache, and sore throat.
  • Cough: May occur especially when starting treatment.
  • Back pain: Reported in some patients during clinical studies.

Most side effects are mild to moderate and tend to improve as your body adjusts to the medication.

Serious but Rare Side Effects

While uncommon, some serious side effects require immediate medical attention:

  • Paradoxical bronchospasm: Sudden worsening of breathing immediately after using the inhaler.
  • Serious allergic reactions: Swelling of face, lips, tongue, or throat, severe rash, or difficulty breathing.
  • Urinary retention: Difficulty or inability to urinate, especially in men with enlarged prostate.
  • Narrow-angle glaucoma: Eye pain, vision changes, or seeing halos around lights.
  • Cardiovascular effects: Irregular heartbeat, chest pain, or significant increase in blood pressure.

Contact your healthcare provider immediately if you experience any of these serious side effects.

Important Safety Considerations

Before starting Stiolto Respimat, inform your healthcare provider about your complete medical history, especially if you have:

  • Heart conditions: Including irregular heartbeat, high blood pressure, or heart disease.
  • Prostate problems: Enlarged prostate or difficulty urinating.
  • Eye problems: Glaucoma or increased eye pressure.
  • Kidney problems: Reduced kidney function may affect how your body processes the medication.
  • Seizure disorders: History of seizures or epilepsy.

Stiolto Respimat contains a LABA medication, which carries a boxed warning from the FDA. LABAs may increase the risk of asthma-related death when used alone, but this medication is not approved for treating asthma.

What to Expect When Starting Treatment

When you begin using Stiolto Respimat, it’s important to have realistic expectations about how the medication works:

Timeline for Improvement

You may notice some improvement in breathing within the first few doses, but it typically takes several days to weeks to experience the full benefits. Unlike rescue inhalers that work immediately, Stiolto Respimat is designed for long-term symptom management.

Monitoring Your Response

Your healthcare provider will likely schedule follow-up appointments to assess how well the medication is working. They may use spirometry tests to measure improvements in lung function and ask about your daily symptoms and quality of life.

Rescue Medication

Continue carrying your rescue inhaler (such as albuterol) for sudden breathing difficulties. Stiolto Respimat is not designed to treat acute COPD exacerbations or breathing emergencies.

Cost Considerations and Affordability

The cost of COPD medications can be a significant concern for many patients. Brand-name inhalers like Stiolto Respimat are often expensive, especially for those without adequate insurance coverage or those in Medicare coverage gaps.

If you’re concerned about medication costs, discuss options with your healthcare provider. Some patients find that paying cash through established pharmacy networks can provide more predictable pricing. Universal Drugstore offers transparent cash pricing for many prescription medications, including specialty inhalers, which can help patients budget for their essential COPD treatments.

Your healthcare provider or pharmacist can help you explore all available options to make your medication more affordable.

Living Well with COPD and Stiolto Respimat

Managing COPD effectively involves more than just taking medication. Consider these lifestyle strategies that work well alongside your Stiolto Respimat treatment:

Pulmonary Rehabilitation

Many patients benefit from structured exercise and education programs designed specifically for people with lung diseases. These programs can help improve your exercise tolerance and teach you breathing techniques.

Avoiding Triggers

Identify and minimize exposure to things that worsen your COPD symptoms, such as air pollution, smoke, strong fragrances, or extreme weather conditions.

Vaccinations

Stay current with pneumonia and annual flu vaccines to reduce your risk of respiratory infections that can worsen COPD symptoms.

When to Contact Your Healthcare Provider

Regular communication with your healthcare team is essential for optimal COPD management. Contact your provider if you experience:

  • Worsening symptoms: Increased shortness of breath, cough, or mucus production.
  • Reduced effectiveness: Your usual activities become more difficult despite taking your medication.
  • Signs of infection: Fever, colored mucus, or feeling generally unwell.
  • Side effects: Any concerning symptoms that may be related to your medication.
  • Questions about technique: If you’re unsure about proper inhaler use.

Your healthcare provider can adjust your treatment plan, provide additional medications, or recommend other interventions to help manage your COPD effectively.

The Bottom Line

Stiolto Respimat represents an important treatment option for people with COPD who have severe breathing problems. By combining two different types of long-acting bronchodilators, this once-daily inhaler can help improve lung function and reduce symptoms when used consistently as prescribed.

Take your medication as directed, maintain regular follow-up appointments, and don’t hesitate to ask questions about your treatment plan. With proper management, many people with COPD can maintain active, fulfilling lives while effectively controlling their symptoms.

Remember that COPD is a progressive condition, and your treatment needs may change over time. Stay engaged with your healthcare provider and be open about how you’re feeling and functioning. This ongoing communication helps ensure that your treatment plan continues to meet your needs and supports your best possible quality of life.

References

Related Conditions